StratDeck

Two stocks in Healthcare

Johnson & Johnson vs Regeneron Pharmaceuticals: profit, growth, debt and price compared

Regeneron Pharmaceuticals is stronger on 5 of 7 figures: profit margin, sales growth, debt, price for its expected profit and price trend. Johnson & Johnson is stronger on 1: dividend.

Figures as of 18 November 2026SEC EDGARYahoo Finance
Explore Johnson & Johnson's storyWhere next ↓

Save both stocks to your watchlist and revisit their latest fundamentals.

Johnson & Johnson and Regeneron Pharmaceuticals side by side
Johnson & JohnsonJNJRegeneron PharmaceuticalsREGN
Net margin16.2%Stronger: 28.5%
Revenue growth, past year+5.86%Stronger: +36.27%
Debt to equity54.8%Stronger: 8.1%
Forward P/E23.5×Stronger: 13.3×
Dividend yieldStronger: 1.94%0.39%
AnalystsBuy · 22Buy · 27
From its 200-day average+10.2%Stronger: +24.2%

Share price over the past year

  • Johnson & Johnson+36.3%
  • Regeneron Pharmaceuticals+30.4%

18 Nov 202518 Nov 2026

Johnson & Johnson or Regeneron Pharmaceuticals: which is stronger?

  • REGN

    Which is more profitable?

    Regeneron Pharmaceuticals keeps more of each sale as profit: 28.5% against 16.2%.

  • REGN

    Which is growing its sales faster?

    Regeneron Pharmaceuticals is growing its sales faster: +36.27% over the past year, against +5.86%.

  • REGN

    Which has borrowed less?

    Regeneron Pharmaceuticals has borrowed less: its debt is 8.1% of what its shareholders own, against 54.8% for Johnson & Johnson.

  • REGN

    Which costs less for the profit it is expected to make?

    Regeneron Pharmaceuticals costs less for the profit it is expected to make: 13.3× its forward earnings, against 23.5×.

  • JNJ

    Which pays more in dividends?

    Johnson & Johnson pays more back in dividends for what a share costs: 1.94% a year, against 0.39%.

  • Which do analysts rate higher?

    Analysts rate both the same: Buy.

  • REGN

    Which is in the stronger price trend?

    Regeneron Pharmaceuticals' price is in the stronger trend: 24.2% above its 200-day average, against 10.2% above.

What each company does

JNJJohnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.

Reports results on 26 January 2027

REGNRegeneron Pharmaceuticals

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide.

Reports results on 28 January 2027

This comparison is just the starting point.

Discover opportunities, understand companies and compare investments in one place. See how StratDeck works

Keep researching

Where next

Every US healthcare comparison

Free email

Up to speed in minutes, four times a week

Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.

Early access

Become a StratDeck founding user

Use StratDeck, tell us what's missing, and help decide what we build next.

100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.